Search results

1 – 10 of 15
Expert briefing
Publication date: 2 February 2021

Indeed, by bargaining hard with vaccine providers and opting for a more deliberate approval process, EU countries are considerably behind the United Kingdom and United States in…

Expert briefing
Publication date: 9 April 2021

Government authorities, including in the United States, are speeding up licensing for clinical trials of these controlled drugs. Substantial philanthropic funding supports…

Expert briefing
Publication date: 17 February 2021

Cannabis pharmaceuticals have experienced dramatic growth in recent years as regulatory approvals have increased. The sector’s expansion deepens contradictions within the…

Expert briefing
Publication date: 5 November 2021
Expert Briefings Powered by Oxford Analytica

Prospects for India in 2022

Meanwhile, GDP is projected by the Reserve Bank of India (RBI) to grow by 9.5% in the fiscal year ending March, rebounding from its 7.3% contraction in 2020/21. Economic goals…

Expert briefing
Publication date: 20 November 2020

Diversion from legitimate pharmaceutical stocks, counterfeiting, adulteration and false labelling are key problems. National and international responses emphasising stricter…

Executive summary
Publication date: 14 April 2021

INDIA: Vaccine imports should help step up roll-out

Expert briefing
Publication date: 19 August 2019

The impact on Greece of a no-deal Brexit.

Executive summary
Publication date: 3 September 2018

EU/UK: Brexit will impact pharmaceutical industries

Details

DOI: 10.1108/OXAN-ES238201

ISSN: 2633-304X

Keywords

Geographic
Topical
Expert briefing
Publication date: 29 March 2019

Expense to the public is also a concern both parties share when it comes to pharmaceutical prices; both want to see reductions. This has become a major political issue, with…

Details

DOI: 10.1108/OXAN-DB242871

ISSN: 2633-304X

Keywords

Geographic
Topical
1 – 10 of 15